Multiple actions of f-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 22, 2013, Pages 8906-8911

  Smith, Jennifer J ^a   Vetter, Irina ^a   Lewis, Richard J ^a   Peigneur, Steve ^b   Tytgat, Jan ^b   Lam, Alexander ^c   Gallant, Esther M ^c   Beard, Nicole A ^d   Alewood, Paul F ^a,b   Dulhunty, Angela F ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Australian National University   (Australia)

^d UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTOXIN; RYANODINE RECEPTOR; SCORPION DISULFIDE DIRECTED HAIRPIN TOXIN; SCORPION INHIBITOR CYSTINE KNOT TOXIN; SCORPION VENOM; TOXIN; UNCLASSIFIED DRUG; CALCIUM CHANNEL L TYPE; DISULFIDE; TRITIUM;

ARTICLE; BINDING SITE; CALCIUM TRANSPORT; MALIGNANT HYPERTHERMIA; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; ELECTROPHYSIOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MISSENSE MUTATION; MOLECULAR GENETICS; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OOCYTE; PHYSIOLOGY; PROTEIN FOLDING; RABBIT; RAT; SEQUENCE ALIGNMENT; SOLID PHASE SYNTHESIS; SPINAL GANGLION; SYNTHESIS; XENOPUS LAEVIS;

ANIMALIA; MAMMALIA; SCORPIONES;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM CHANNELS, L-TYPE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISULFIDES; ELECTROPHYSIOLOGICAL PROCESSES; GANGLIA, SPINAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEURONS; OOCYTES; PROTEIN FOLDING; RABBITS; RATS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SCORPION VENOMS; SEQUENCE ALIGNMENT; SOLID-PHASE SYNTHESIS TECHNIQUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRITIUM; XENOPUS LAEVIS;

MLCS; MLOWN;

EID: 84878468402     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1214062110     Document Type: Article

References (52)

1. Koch GL (1990) The endoplasmic reticulum and calcium storage. BioEssays 12(11): 527-531.
2. Dulhunty AF, Casarotto MG, Beard NA (2011) The ryanodine receptor: A pivotal Ca2+ regulatoryproteinandpotential therapeuticdrugtarget.CurrDrugTargets 12(5):709-723.
3. Kimlicka L, Van Petegem F (2011) The structural biology of ryanodine receptors. Sci China Life Sci 54(8):712-724.
4. Zorzato F, et al. (1990) Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 265(4):2244-2256.
5. Otsu K, et al. (1990) Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 265:23):13472-13483.
6. McPherson PS, Campbell KP (1990) Solubilization and biochemical characterization of the high affinity [3H]ryanodine receptor from rabbit brain membranes. J Biol Chem 265(30):18454-18460.
7. Martin C, Chapman KE, Seckl JR, Ashley RH (1998) Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum. Neuroscience 85(1):205-216.
8. Ali SZ, Taguchi A, Rosenberg H (2003) Malignant hyperthermia. Best Pract Res Clin Anaesthesiol 17(4):519-533.
9. Priori SG, et al. (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103(2): 196-200.
10. Ullrich ND, Valdivia HH, Niggli E (2012) PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca(2+) sensitivity. J Mol Cell Cardiol 53(1):33-42.
11. Gonzalez DR, Treuer AV, Castellanos J, Dulce RA, Hare JM (2010) Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. J Biol Chem 285(37):28938-28945.
12. Bellinger AM, et al. (2009) Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15(3):325-330.
13. Lü N, et al. (2012) Involvement of ryanodine receptors in tetanic sciatic stimulationinduced long-term potentiation of spinal dorsal horn and persistent pain in rats. J Neurosci Res 90(5):1096-1104.
14. Berridge MJ (2011) Calcium signalling and Alzheimer's disease. Neurochem Res 36(7): 1149-1156.
15. Takano K, et al. (2012) An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity. Hum Mol Genet 21(20): 4497-4507.
16. Pessah IN, Stambuk RA, Casida JE (1987) Ca2+-activated ryanodine binding: Mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. Mol Pharmacol 31(3):232-238.
17. Meissner G, el-Hashem A (1992) Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel. Mol Cell Biochem 114(1-2):119-123.
18. Buck E, Zimanyi I, Abramson JJ, Pessah IN (1992) Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J Biol Chem 267(33): 23560-23567.
19. Bidasee KR, Xu L, Meissner G, Besch HR, Jr. (2003) Diketopyridylryanodine has three concentration-dependent effects on the cardiac calcium-release channel/ryanodine receptor. J Biol Chem 278(16):14237-14248.
20. el-Hayek R, Lokuta AJ, Arévalo C, Valdivia HH (1995) Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms. J Biol Chem 270(48):28696-28704.
21. Dulhunty AF, Curtis SM, Watson S, Cengia L, Casarotto MG (2004) Multiple actions of imperatoxin A on ryanodine receptors: Interactions with the II-III loop "A" fragment. J Biol Chem 279(12):11853-11862.
22. Chen L, et al. (2003) Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism. J Biol Chem 278(18):16095-16106.
23. Schwartz EF, et al. (2009) Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors. Br J Pharmacol 157(3):392-403.
24. Ram N, et al. (2008) Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells. J Biol Chem 283(40):27048-27056.
25. Mosbah A, et al. (2000) A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel. Proteins 40(3):436-442.
26. Daly NL, Craik DJ (2011) Bioactive cystine knot proteins. Curr Opin Chem Biol 15(3): 362-368.
27. Rodriguez de la Vega RC, Possani LD (2005) Overview of scorpion toxins specific for Na+ channels and related peptides: Biodiversity, structure-function relationships and evolution. Toxicon 46(8):831-844.
28. Fry BG, et al. (2009) The toxicogenomic multiverse: Convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 10:483-511.
29. Zhu S, Darbon H, Dyason K, Verdonck F, Tytgat J (2003) Evolutionary origin of inhibitor cystine knot peptides. FASEB J 17(12):1765-1676.
30. Wang X, et al. (2000) Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nat Struct Biol 7(6):505-513.
31. Smith JJ, et al. (2011) Unique scorpion toxin with a putative ancestral fold provides insight into evolution of the inhibitor cystine knot motif. Proc Natl Acad Sci USA 108:26):10478-10483.
32. Copello JA, Barg S, Onoue H, Fleischer S (1997) Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors. Biophys J 73(1):141-156.
33. Tae HS, et al. (2011) Cyclization of the intrinsically disordered a1S dihydropyridine receptor II-III loop enhances secondary structure and in vitro function. J Biol Chem 286 (25):22589-22599.
34. Devor M (1999) Unexplained peculiarities of the dorsal root ganglion. Pain 6(Suppl 6): S27-S35.
35. Rush AM, Cummins TR, Waxman SG (2007) Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol 579(Pt 1):1-14.
36. Melli G, Hoke A (2009) Dorsal Root Ganglia Sensory Neuronal Cultures: A tool for drug discovery for peripheral neuropathies. Expert Opin Drug Discov 4(10):1035-1045.
37. Yotsu-Yamashita M, et al. (2004) The structure of zetekitoxin AB, a saxitoxin analog from the Panamanian golden frog Atelopus zeteki: A potent sodium-channel blocker. Proc Natl Acad Sci USA 101(13):4346-4351.
38. Estève E, et al. (2005) Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem 280(13): 12833-12839.
39. Mabrouk K, et al. (2007) Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration. Biochim Biophys Acta 1768(10): 2528-2540.
40. Clackson T, Wells JA (1995) A hot spot of binding energy in a hormone-receptor interface. Science 267(5196):383-386.
41. Sun H, Greathouse DV, Andersen OS, Koeppe RE, 2nd (2008) The preference of tryptophan for membrane interfaces: Insights from N-methylation of tryptophans in gramicidin channels. J Biol Chem 283(32):22233-22243.
42. Echols N, et al. (2002) Comprehensive analysis of amino acid and nucleotide composition in eukaryotic genomes, comparing genes and pseudogenes. Nucleic Acids Res 30(11):2515-2523.
43. Tripathy A, Resch W, Xu L, Valdivia HH, Meissner G (1998) Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle. J Gen Physiol 111(5):679-690.
44. Lukács B, et al. (2008) Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor. Biophys J 95(7):3497-3509.
45. Seo IR, Kang DE, Song DW, Kim H (2011) Both basic and acidic amino acid residues of IpTx(a) are involved in triggering substate of RyR1. J Biomed Biotechnol 2011:386384.
46. Horita S, et al. (2011) Solution structure of a short-chain insecticidal toxin LaIT1 from the venom of scorpion Liocheles australasiae. Biochem Biophys Res Commun 411(4): 738-744.
47. El-Hayek R, Ikemoto N (1998) Identification of the minimum essential region in the IIIII loop of the dihydropyridine receptor alpha 1 subunit required for activation of skeletal muscle-type excitation-contraction coupling. Biochemistry 37(19):7015-7020.
48. Casarotto MG, et al. (2000) A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop. J Biol Chem 275(16):11631-11637.
49. Fields GB, Noble RL (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35(3):161-214.
50. Laver DR, et al. (1995) Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle. J Membr Biol 147(1):7-22.
51. Ahern GP, Junankar PR, Dulhunty AF (1994) Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506. FEBS Lett 352(3):369-374.
52. Kimura T, et al. (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14(15):2189-2200.